
Qupitaz 4000mg/500mg Injection
Marketer
Quepreon Biologicals Pvt Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Qupitaz 4000mg/500mg Injection
Combiflox 4000mg/500mg injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by healthcare providers, the dosage and frequency are determined by your physician based on the infection's severity. Strict adherence to your doctor's prescription is crucial. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rash, and injection site reactions (pain, swelling, redness). Persistent or worsening side effects warrant immediate medical attention. Prior to use, disclose any antibiotic allergies, liver, or kidney issues to your doctor; adjustments to dosage or alternative medication may be necessary. Under medical guidance, this injection is generally considered safe during pregnancy and lactation.
Uses of Qupitaz 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Qupitaz 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Qupitaz 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Qupitaz 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Qupitaz 4000mg/500mg Injection works:
Qupitaz 4000mg/500mg Injection unites Piperacillin, a bacteria-fighting antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum's role is to counteract bacterial resistance mechanisms, thus bolstering Piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Qupitaz 4000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Qupitaz, in its 4000mg/500mg formulation, is typically deemed safe for use during gestation. Preclinical trials using animal models revealed minimal or no negative consequences for fetal development; however, data from human trials remains scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication, Qupitaz 4000mg/500mg, poses no known breastfeeding risk. Research in humans indicates minimal to negligible transfer of the drug into breast milk, presenting no apparent harm to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Qupitaz 4000mg/500mg Injection on driving ability is undetermined. Refrain from operating a vehicle if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Qupitaz 4000mg/500mg Injection cautiously. A modified dosage of Qupitaz 4000mg/500mg Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Qupitaz 4000mg/500mg Injection in individuals with hepatic impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Qupitaz 4000mg/500mg Injection :
Omit a scheduled Qupitaz 4000mg/500mg Injection? Seek your physician's guidance.
Facts to Know About Qupitaz 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
